Last reviewed · How we verify
NCT06957899: PDPHPatients
Optic Nerve Sheath Diameter in Postspinal Headache
trial in Post-Dural Puncture Headache in 40 participants. Completed in 5 December 2025.
30 September 2025
Quick facts
| Lead sponsor | Konya City Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 July 2025 |
| Primary completion | 30 September 2025 |
| Estimated completion | 5 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Post-Dural Puncture Headache — all drugs for Post-Dural Puncture Headache →
Sponsor
Konya City Hospital
Who can join
Adults 18 to 75, any sex, with Post-Dural Puncture Headache. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the relationship between spinal needle size and optic nerve sheath diameter (ONSD) in patients who develop post-dural puncture headache (PDPH) after spinal anesthesia. ONSD is measured using ultrasound, which helps estimate changes in brain pressure. The study also examines whether the severity of headache is related to ONSD. Adult patients aged 18 to 75 years who develop PDPH will be included. This research will be conducted at Konya City Hospital and is expected to last for approximately six months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06957899
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-Dural Puncture Headache
Currently open trials in the same condition.
- NCT06824025 — Comparison of Nebulized Neostigmine/Atropine Versus Lignocaine in Treating Acute Post-dural Puncture Headache Following · EARLY_PHASE1 · recruiting
- NCT07515456 — Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache · NA · recruiting
- NCT06253754 — Pathophysiological Mechanisms and Implication of Treatment in Postural Puncture Headache · recruiting
- NCT06444737 — Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia · NA · recruiting
- NCT05804448 — Effect of Altitude on Postdural Puncture Headache After Caesarean Delivery · recruiting
Other Konya City Hospital trials
Trials by the same sponsor.
- NCT07504705 — Comparison of Intertransverse Process and Erector Spinae Plane Blocks in Acute Postoperative Analgesia Management for La · NA · not yet recruiting
- NCT07525167 — Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data · not yet recruiting
- NCT07335250 — Intertransverse Process Block for Postoperative Analgesia After Thoracotomy and Lobectomy · NA · recruiting
- NCT07511985 — Effect of Rebound Pain on Chronic Postsurgical Pain After Total Knee Arthroplasty · not yet recruiting
- NCT07295158 — Effect of Sevoflurane vs Desflurane on Mechanical Power in Laparoscopic Cholecystectomy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06957899 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Konya City Hospital
- Last refreshed: 9 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06957899.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing